For the experiment CLL‐like cells (B220lowCD5+), as well as all B cells, which means in this case conventional B2 cells combined with the B220low CD5+ population, were selected as indicated in Fig 7A. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.